MIR MedMira Inc.

0.0419USD0.0600 CAD · TSXV+10.00%Mkt Cap: 26.98M USDP/E: —

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that de…

Key Statistics

Company
Market Cap26.98M USD
Enterprise Value—
Revenue (TTM)259.04K USD
Gross Profit120.83K USD
Net Income (TTM)-3.16M USD
Revenue/Share0.0007 USD
Last Price0.0419 USD
Fiscal Year EndJul 2025
MR QuarterApr 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA58501R1029
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S104.15
P/B-1.57
EPS (TTM)0.00 USD
EPS (Forward)—
52W Range
0.021043% of range0.0699
52W High0.0699 USD
52W Low0.0210 USD
Profitability
Gross Margin71.87%
Oper. Margin-531.16%
EBITDA Margin0.00%
Profit Margin-1881.18%
ROE20.05%
ROA-122.89%
ROIC—
ROCE—
Growth
Revenue Growth308.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.20M USD
CapEx (TTM)5.22K USD
FCF Margin-32.13%
FCF Yield-0.31%
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.47
Current Ratio0.06
Quick Ratio0.05
Book Value/Sh-0.02 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.701.73M
Float209.72M
Insiders65.54%
Institutions0.00%
Short Interest
Short Ratio0.3d
Short % Out.0.00%
Shares Short10.13K
Short (prev mo.)1.99K
Technical
SMA 500.0432 (-2.9%)
SMA 2000.0453 (-7.4%)
Beta0.87
S&P 52W Chg12.00%
Avg Vol (30d)102.58K
Avg Vol (10d)215.29K
Technical Indicators
RSI (14)50.6
MACD-0.0034
MACD Signal-0.0037
MACD Hist.+0.0004
BB Upper0.0456 USD
BB Middle0.0367 USD
BB Lower0.0278 USD
BB Width48.66%
ATR (14)0.0038 USD
Vol Ratio (20d)0.83x

About MedMira (CVE: MIR)

›

MedMira (CVE: MIR) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.0600 CAD on 18 November 2026, down 45.0% over 52 weeks. Its 52-week range is 0.0300 CAD to 0.1000 CAD: the price is 40.0% below the high and 100.0% above the low.

Its market capitalisation is 38.60M CAD.

MedMira reports return on equity of 20.1% and revenue up 308.0% year over year.

Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 27 November 2026.